Kiniksa Pharmaceuticals Q3 EPS $0.56 Beats $0.37 Estimate, Sales $285.970M Beat $260.611M Estimate
Benzinga Newsdesk 6 days ago
NewsEarningsEarnings Beats
Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.37 by 51.35 percent. This is a 143.48 percent increase over earnings of $0.23 per
Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.37 by 51.35 percent. This is a 143.48 percent increase over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $285.970 million which beat the analyst consensus estimate of $260.611 million by 9.73 percent. This is a 58.12 percent increase over sales of $180.855 million the same period last year.